ESR1 and serous adenocarcinoma: To confirm the binding of our identified TFs in ovarian cancer, we performed ChIP-seq experiments for FOXA1, PITX1, and ERα in the ovarian cancer cell line PEO4, derived from a poorly differentiated serous adenocarcinoma [56].